---
title: "Guangdong Biolight Meditech Co., Ltd. (300246.SZ)"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/300246.SZ.md"
symbol: "300246.SZ"
name: "Guangdong Biolight Meditech Co., Ltd."
industry: "Health Care Equipment"
datetime: "2026-05-20T22:34:11.911Z"
locales:
  - [en](https://longbridge.com/en/quote/300246.SZ.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/300246.SZ.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/300246.SZ.md)
---

# Guangdong Biolight Meditech Co., Ltd. (300246.SZ)

## Company Overview

Guangdong Biolight Meditech Co., Ltd. engages in the research and development, production, sale, and service of medical devices products and solutions in China. It operates in two segments, Life Information and Support, and Kidney Disease. The company offers emergency and critical care monitor, subcritical care monitor, general ward monitor, outpatient monitor, neonatal monitor, infusion pump, electrocardiograph, maternal and fetal monitor, defibrillator, multifunctional suspension device, internet of things, and central station; hemodiafiltration equipment, peritoneal dialysis equipment, liquid supply system, and hemodialysis water equipment; and finger clip oximeter, sphygmomanometer, fetal heart rate monitor, body temperature monitoring system, and home medical mall, as well as hemoperfusion devices, high throughput and low flu hemodialyzer, hemodialysis concentrate, dry powder, citric acid disinfectant, tube/puncture needle, dialysate filter, and dialysis fluid filter.

| Item | Detail |
|------|--------|
| Industry | Health Care Equipment |
| Exchange | CN Market |
| Website | [www.blt.com.cn](https://www.blt.com.cn) |

## Key Drivers
> *AI-analyzed key factors driving this stock's performance*


## Longbridge Financial Score™: D
> *Longbridge Financial Score™ — Proprietary multi-factor rating model by Longbridge*
> Updated: 2026-05-20T04:30:09.000Z

**Overall: D (0.67)**

**Industry**: Health Care Equipment

| Metric | Value |
|--------|-------|
| Industry Ranking | 61 / 64 |
| Industry Median | C |
| Industry Average | C |

- **Style**: Blend - Stocks in which the company has both growth and mature businesses.
- **Scale**: Small - The company's operation has a high degree of growth and volatility, making it easy to achieve high investment returns.

**Multi Score**: D

#### Style Score Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue YoY | 4.73% |  |
| Net Profit YoY | -50.44% |  |
| P/B Ratio | 5.06 |  |
| Dividend Ratio | 0.24% |  |

#### Size Score Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Market Cap | 5460588836.57 |  |
| Revenue | 1092592588.86 |  |

#### Multi Score Score: D

| Indicator | Value | Rating |
|-----------|-------|--------|
| ROE | 0.00% | D |
| Profit Margin | 0.00% | D |
| Gross Margin | 23.81% | C |
| Revenue YoY | 4.73% | C |
| Net Profit YoY | -50.44% | D |
| Total Assets YoY | 3.20% | C |
| Net Assets YoY | -7.91% | D |
| Cash Flow Margin | -113.13% | E |
| OCF YoY | 4.73% | C |
| Turnover | 0.00 | E |
| Gearing Ratio | 50.97% | C |

```chart-data:radar
{
  "title": "Longbridge Financial Score - Guangdong Biolight Meditech Co., Ltd.",
  "chart_type": "radar",
  "dimensions": [
    {
      "name": "Style Score",
      "grade": "",
      "indicators": [
        {
          "name": "Revenue YoY",
          "value": "4.73%",
          "rating": ""
        },
        {
          "name": "Net Profit YoY",
          "value": "-50.44%",
          "rating": ""
        },
        {
          "name": "P/B Ratio",
          "value": "5.06",
          "rating": ""
        },
        {
          "name": "Dividend Ratio",
          "value": "0.24%",
          "rating": ""
        }
      ]
    },
    {
      "name": "Size Score",
      "grade": "",
      "indicators": [
        {
          "name": "Market Cap",
          "value": "5460588836.57",
          "rating": ""
        },
        {
          "name": "Revenue",
          "value": "1092592588.86",
          "rating": ""
        }
      ]
    },
    {
      "name": "Multi Score",
      "grade": "D",
      "indicators": [
        {
          "name": "ROE",
          "value": "0.00%",
          "rating": "D"
        },
        {
          "name": "Profit Margin",
          "value": "0.00%",
          "rating": "D"
        },
        {
          "name": "Gross Margin",
          "value": "23.81%",
          "rating": "C"
        },
        {
          "name": "Revenue YoY",
          "value": "4.73%",
          "rating": "C"
        },
        {
          "name": "Net Profit YoY",
          "value": "-50.44%",
          "rating": "D"
        },
        {
          "name": "Total Assets YoY",
          "value": "3.20%",
          "rating": "C"
        },
        {
          "name": "Net Assets YoY",
          "value": "-7.91%",
          "rating": "D"
        },
        {
          "name": "Cash Flow Margin",
          "value": "-113.13%",
          "rating": "E"
        },
        {
          "name": "OCF YoY",
          "value": "4.73%",
          "rating": "C"
        },
        {
          "name": "Turnover",
          "value": "0.00",
          "rating": "E"
        },
        {
          "name": "Gearing Ratio",
          "value": "50.97%",
          "rating": "C"
        }
      ]
    }
  ]
}
```

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | -62.59 | 60/64 | - | - | - |
| PB | 5.30 | 56/64 | 3.19 | 2.06 | 1.89 |
| PS (TTM) | 5.23 | 22/64 | 3.49 | 2.30 | 2.11 |
| Dividend Yield | 0.23% | 48/64 | 0.58% | 0.37% | 0.30% |

## Peer Comparison

| Rank | Name | Profit | Growth | Operation | Security | Cash | Rating |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 01 | APT (688617.SH) | A | B | B | A | B | A |
| 02 | United Imaging Healthcare (688271.SH) | B | A | C | B | B | B |
| 03 | iRay (688301.SH) | B | A | D | C | A | B |
| 04 | YUYUE MEDICAL (002223.SZ) | B | C | C | A | C | B |
| 05 | Insight Lifetech (688712.SH) | B | A | E | A | A | B |

## Institutional View

### Analyst Rating Distribution

> As of 2024-05-19T16:00:00.000Z

Total Analysts: **1**

| Rating | Count | Percentage |
|--------|-------|-----------| 
| Buy | 1 | 100% |

### Target Price Forecast

| Metric | Price |
|--------|-------|
| Current Price | 21.57 |
| Highest Target | undefined |
| Lowest Target | undefined |

## References

- [Company Overview — Profile, executives, shareholders, business breakdown](https://longbridge.com/en/quote/300246.SZ/overview.md)
- [Financial Reports — Income, balance sheet, cash flow, dividends](https://longbridge.com/en/quote/300246.SZ/norm.md)
- [Related News](https://longbridge.com/en/quote/300246.SZ/news.md)
- [Filings — Company announcements and regulatory filings](https://longbridge.com/en/quote/300246.SZ/filings.md)

---

> **Disclaimer: This article is for reference only and does not constitute any investment advice.**